Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients

Author： vom Dahl Stephan   Poll Ludger   Di Rocco Maja   Ciana Giovanni   Denes Carmencita   Mariani Giuliano   Maas Mario  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.6, 2006-06, pp. : 1045-1064

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombocytosis Associated with Enzyme Replacement Therapy in Gaucher Disease

By  

Acta Haematologica, Vol. 108, Iss. 2, 2002-08 ,pp. : 94-96

Karger

Access to resources Recommend Favorite

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long‐term data from phase III clinical trials

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 584-591

John Wiley & Sons Inc

Access to resources Recommend Favorite

ATTEMPT AT ENZYME REPLACEMENT IN GAUCHER DISEASE BY RENAL TRANSPLANTATION

By  

ACTA PAEDIATRICA, Vol. 68, Iss. 5, 1979-09 ,pp. : 475-479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Online Information on Complementary and Alternative Medicine for Cancer Patients: Evidence-Based Recommendations

By  

Oncology Research and Treatment, Vol. 36, Iss. 5, 2013-03 ,pp. : 273-278

Karger

Access to resources Recommend Favorite

An overview on bone manifestations in Gaucher disease

By Mikosch Peter  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 23-24, 2010-12 ,pp. : 609-624

Springer Publishing Company

Access to resources Recommend Favorite